Efficacy and Safety of Immunoglobulin Plus Firsekibart in Patients With Kawasaki Disease

NCT07686770 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

NOT_YET_RECRUITING

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Kawasaki Disease

Interventions

DRUG: IVIG
DRUG: Aspirin
DRUG: Firsekibart

Sponsor

Children's Hospital of Fudan University

Collaborators

[object Object]